Breast Cancer Clinical Trials

Showing 1741-1760 of 5,597 trials

TERMINATEDPhase 1

Avidination for RadionuclideTHerapy in Nonpalpable Breast Cancer

NCT06390241

This is an interventional, open-label, non comparative phase 2 trial enrolling patients with nonpalpable breast cancer

Breast Cancer

Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS18 participantsStarted Jun 2024

Meldola, Forlì Cesena, Italy

RECRUITINGNA

Tailored Axillary Surgery With or Without Axillary Lymph Node Dissection Followed by Radiotherapy in Patients With Clinically Node-positive Breast Cancer (TAXIS)

NCT03513614

RATIONALE: The use of tailored axillary dissection as a tailored procedure will avoid surgical overtreatment by selectively removing the lymph nodes that are affected by the cancer, thereby sparing many women the unnecessary complications of a radical surgery, providing a better quality of life while keeping the same efficacy. PURPOSE: The phase III trial is evaluating the optimal treatment for breast cancer patients in terms of surgery and radiotherapy.

Node-positive Breast Cancer

University Hospital, Basel, Switzerland1,500 participantsStarted Aug 2018

Bethesda, Maryland, United States • Durham, North Carolina, United States • Seattle, Washington, United States +64 more locations

Avidination for RadionuclideTHerapy in Nonpalpable Breast Cancer

Tailored Axillary Surgery With or Without Axillary Lymph Node Dissection Followed by Radiotherapy in Patients With Clinically Node-positive Breast Cancer (TAXIS)

Related Searches

Surgical and Patient Reported Outcomes of Robotic Nipple-Sparing Mastectomy

Comparison of Low-dose Spiral Breast CT With MRI in Major Indications of MRI for Breast Diagnostics

A Study of BTX-A51 in People With Advanced Solid Tumor and Breast Cancer

Personalized Patient Derived Xenograft (pPDX) Modeling to Test Drug Response in Matching Host

The Effect of the Mobile Application-based Support Program on the Outcomes of Breast Cancer Patients in the Pandemic

Trilaciclib in Patients Receiving Sacituzumab Govitecan-hziy for Triple Negative Breast Cancer

Phase II Study of Pembrolizumab and Nab-paclitaxel in HER-2 Negative Metastatic Breast Cancer

Localization of Breast Cancer with the Sirius Pintuition Magnetic Seed

PhII ICb With/Without Erbitux in MBC Pts

The PROMISE Study: Duavee in Women With DCIS

Anastrozole and Letrozole After Surgery for the Treatment of Stage I-III Breast Cancer

The Effect of Body Mass Index and Total Cholesterol Levels on Histopathological Grading in Breast Cancer Patients

BrAin Metastasis in tripLe Negateive Breast Cancer: IvoneScimab and Trop2 ADC

Trastuzumab Deruxtecan With Nivolumab in Advanced Breast and Urothelial Cancer

Exploring the Tumor Micro-Environment with 68Ga-FAPi-46 PET/CT in Breast Cancer

A Study to Investigate the Biological Effects of AZD9833 in Women With ER-positive, HER2 Negative Primary Breast Cancer

Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With Cancer

Patient Outcomes from Second Film-readers and Test Threshold Relaxation in Breast Screening